VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
warfarin우선순위 중간ICSR 검토기타

LITERATURE DETAIL · PMID 42499238

Real-world comparative safety and effectiveness of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation: a prospective cohort study.

Real-world comparative safety and effectiveness of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation: a prospective cohort study.

저자
Nawal Alsubaie, Zafar Ali Shah, Muhammad Ilyas, Amani S Alrossies, Ammena Y Binsaleh, Syed Muzammil Shah
저널
Current medical research and opinion
공개일
2026 Jul 24
연구 유형
기타
DOI
10.1080/03007995.2026.2706317

문헌 요약

Direct oral anticoagulants (DOACs) provide several advantages over warfarin for stroke prevention in atrial fibrillation, particularly among patients with unstable or difficult-to-control international normalized ratio (INR) values. To compare the safety and efficacy of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation (NVAF) e…

PV 검토 포인트

개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.

PubMed에서 원문 정보 보기